188Re-HEDP combined with capecitabine in hormone-refractory prostate cancer patients with bone metastases: a phase I safety and toxicity study
Marnix G. E. H. Lam, Tjitske B. Bosma, Peter P. van Rijk, Bernard A. ZonnenbergVolume:
36
Language:
english
Pages:
9
DOI:
10.1007/s00259-009-1119-8
Date:
September, 2009
File:
PDF, 229 KB
english, 2009